A comprehensive evaluation of outcomes for inflammatory breast cancer

Breast Cancer Research and Treatment

Volumn 117, Issue 3, 2009, Pages 631-641

  Yang, Relin ^a   Cheung, Michael C ^a   Hurley, Judith ^b   Byrne, Margaret M ^a   Huang, Youjie ^c   Zimmers, Teresa A ^a   Koniaris, Leonidas G ^a  

^a UNIVERSITY OF MIAMI MILLER SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF MIAMI   (United States)

^c FLORIDA DEPARTMENT OF HEALTH   (United States)

Author keywords

Breast cancer; Disparity; Outcomes; Race; Socioeconomic status

Indexed keywords

ANTINEOPLASTIC AGENT;

ADJUVANT CHEMOTHERAPY; ADULT; AFRICAN AMERICAN; AGED; AMERICAN INDIAN; ARTICLE; ASIAN; BREAST CANCER; CANCER COMBINATION CHEMOTHERAPY; CANCER GRADING; CANCER HORMONE THERAPY; CANCER RADIOTHERAPY; CANCER REGISTRY; CANCER SURGERY; CAUCASIAN; DISEASE FREE SURVIVAL; ETHNICITY; FEMALE; HISPANIC; HUMAN; INFLAMMATORY BREAST CANCER; MAJOR CLINICAL STUDY; OVERALL SURVIVAL; PACIFIC ISLANDER; POVERTY; PRIORITY JOURNAL; PROGNOSIS; RACE; SOCIAL STATUS; TUMOR VOLUME; UNITED STATES;

ADULT; AFRICAN AMERICANS; AGE FACTORS; AGE OF ONSET; AGED; ANTINEOPLASTIC AGENTS; BREAST NEOPLASMS; COMBINED MODALITY THERAPY; CONTINENTAL POPULATION GROUPS; EUROPEAN CONTINENTAL ANCESTRY GROUP; FEMALE; HISPANIC AMERICANS; HUMANS; MASTECTOMY; MIDDLE AGED; MULTIVARIATE ANALYSIS; PROGNOSIS; RADIOTHERAPY; REGISTRIES; SOCIOECONOMIC FACTORS; SURVIVAL ANALYSIS; TREATMENT OUTCOME;

EID: 70349574165     PISSN: 01676806     EISSN: 15737217     Source Type: Journal    
DOI: 10.1007/s10549-009-0312-6     Document Type: Article

References (34)

1. American Cancer Society, Inc (2004) Cancer facts and figures 2004. American Cancer Society, Inc. Atlanta, GA
2. S Chang SL Parker T Pham AU Buzdar SD Hursting 1998 Inflammatory breast carcinoma incidence and survival: the surveillance, epidemiology, and end results program of the National Cancer Institute, 1975-1992 Cancer 82 12 2366 2372 10.1002/(SICI)1097-0142(19980615)82:12<2366::AID-CNCR10>3.0.CO;2-N 9635529 10.1002/(SICI)1097-0142(19980615)82:12<2366::AID-CNCR10>3.0.CO;2-N 1:STN:280:DyaK1c3pslCmsA%3D%3D (Pubitemid 28283443)
3. PH Levine SC Steinhorn LG Ries JL Aron 1985 Inflammatory breast cancer: the experience of the surveillance, epidemiology, and end results (SEER) program J Natl Cancer Inst 74 2 291 297 3856043 1:STN:280:DyaL2M7jsFGnuw%3D%3D
4. Yang R, Cheung MC, Franceschi D, Hurley J, Huang Y, Livingstone AS, Koniaris LG African American and low socioeconomic status patients have a worse prognosis for invasive ductal and lobular breast carcinoma: do screening criteria need to change? J Am Coll Surg (in press)
5. JB Campbell 2002 Breast cancer-race, ethnicity, and survival: a literature review Breast Cancer Res Treat 74 2 187 192 10.1023/A:1016178415129 12186379 10.1023/A:1016178415129 (Pubitemid 34816224)
6. LX Clegg FP Li BF Hankey K Chu BK Edwards 2002 Cancer survival among US whites and minorities: a SEER (surveillance, epidemiology, and end results) program population-based study Arch Intern Med 162 17 1985 1993 10.1001/archinte.162.17.1985 12230422 10.1001/archinte.162.17.1985
7. JW Eley HA Hill VW Chen DF Austin MN Wesley HB Muss RS Greenberg RJ Coates P Correa CK Redmond, et al. 1994 Racial differences in survival from breast cancer. Results of the National Cancer Institute Black/White Cancer Survival Study JAMA 272 12 947 954 10.1001/jama.272.12.947 8084062 10.1001/jama.272.12.947 1:STN:280:DyaK2czms1Sguw%3D%3D (Pubitemid 24288549)
8. A Ghafoor A Jemal E Ward V Cokkinides R Smith M Thun 2003 Trends in breast cancer by race and ethnicity CA Cancer J Clin 53 6 342 355 15224974 10.3322/canjclin.53.6.342
9. SA Joslyn 2002 Racial differences in treatment and survival from early-stage breast carcinoma Cancer 95 8 1759 1766 10.1002/cncr.10827 12365025 10.1002/cncr.10827
10. CI Li 2005 Racial and ethnic disparities in breast cancer stage, treatment, and survival in the United States Ethn Dis 15 (2 Suppl 2) S5 S9 15822829
11. KW Hance WF Anderson SS Devesa HA Young PH Levine 2005 Trends in inflammatory breast carcinoma incidence and survival: the surveillance, epidemiology, and end results program at the National Cancer Institute J Natl Cancer Inst 97 13 966 975 15998949
12. DeNavas-Walt C, Proctor BD, Mill R (2007) Current population reports. US Census Bureau: P60-226. http://quickfacts.census.gov
13. Surveillance Epidemiology, and End Results (SEER) Program ( http://www.seer.cancer.gov ) Limited-Use Data (1973-2005), National Cancer Institute, DCCPS, Surveillance Research Program, Cancer Statistics Branch, released April 2008, based on the November 2007 submission
14. United States Census Bureau (2001) Profile of general demographic characteristics: 2000. http://factfindercensus.gov. Accessed 15 Nov 2008
15. MR Kell M Morrow 2005 Surgical aspects of inflammatory breast cancer Breast Dis 22 67 73 16735788
16. AU Buzdar ED Montague JL Barker GN Hortobagyi GR Blumenschein 1981 Management of inflammatory carcinoma of breast with combined modality approach-an update Cancer 47 11 2537 2542 10.1002/1097-0142(19810601)47: 11<2537::AID-CNCR2820471102>3.0.CO;2-X 6790155 10.1002/1097-0142(19810601) 47:11<2537::AID-CNCR2820471102>3.0.CO;2-X 1:STN:280:DyaL3M3lvVamtQ%3D%3D (Pubitemid 11113713)
17. CD Knight Jr JK Martin Jr JS Welch JN Ingle TA Gaffey A Martinez 1986 Surgical considerations after chemotherapy and radiation therapy for inflammatory breast cancer Surgery 99 4 385 391 3952663
18. B Zylberberg J Salat-Baroux JH Ravina D Dormont JP Amiel P Diebold V Izrael 1982 Initial chemoimmunotherapy in inflammatory carcinoma of the breast Cancer 49 8 1537 1543 10.1002/1097-0142(19820415)49:8<1537::AID- CNCR2820490805>3.0.CO;2-E 7066861 10.1002/1097-0142(19820415)49:8<1537:: AID-CNCR2820490805>3.0.CO;2-E 1:STN:280:DyaL387mt1eqsw%3D%3D
19. MM Black FD Speer 1957 Nuclear structure in cancer tissues Surg Gynecol Obstet 105 1 97 102 13442910 1:STN:280:DyaG2s%2FovFKnsg%3D%3D
20. M Cristofanilli AU Buzdar GN Hortobagyi 2003 Update on the management of inflammatory breast cancer Oncologist 8 2 141 148 10.1634/theoncologist.8-2-141 12697939 10.1634/theoncologist.8-2-141 1:CAS:528:DC%2BD3sXjsVOmt7w%3D (Pubitemid 36428280)
21. M Panades IA Olivotto CH Speers T Shenkier TA Olivotto L Weir SJ Allan PT Truong 2005 Evolving treatment strategies for inflammatory breast cancer: a population-based survival analysis J Clin Oncol 23 9 1941 1950 10.1200/JCO.2005.06.233 15774787 10.1200/JCO.2005.06.233 (Pubitemid 46211373)
22. DM Morris 1983 Mastectomy in the management of patients with inflammatory breast cancer J Surg Oncol 23 4 255 258 10.1002/jso.2930230408 6876800 10.1002/jso.2930230408 1:STN:280:DyaL3s3mvFyqtw%3D%3D
23. RY Fleming L Asmar AU Buzdar MD McNeese FC Ames MI Ross SE Singletary 1997 Effectiveness of mastectomy by response to induction chemotherapy for control in inflammatory breast carcinoma Ann Surg Oncol 4 6 452 461 10.1007/BF02303668 9309333 10.1007/BF02303668 1:STN:280:DyaK2svlsV2htQ%3D%3D
24. EK Abdalla JN Vauthey LM Ellis V Ellis R Pollock KR Broglio K Hess SA Curley 2004 Recurrence and outcomes following hepatic resection, radiofrequency ablation, and combined resection/ablation for colorectal liver metastases Ann Surg 239 6 818 825 10.1097/01.sla.0000128305.90650.71 15166961 10.1097/01.sla.0000128305.90650.71 (discussion 817-825) (Pubitemid 38669432)
25. J Dauplat G Le Bouedec C Pomel C Scherer 2000 Cytoreductive surgery for advanced stages of ovarian cancer Semin Surg Oncol 19 1 42 48 10.1002/1098-2388(200007/08)19:1<42::AID-SSU7>3.0.CO;2-M 10883023 10.1002/1098-2388(200007/08)19:1<42::AID-SSU7>3.0.CO;2-M 1:STN:280:DC%2BD3cvgslehsA%3D%3D (Pubitemid 30439314)
26. JH Goldie AJ Coldman 1979 A mathematic model for relating the drug sensitivity of tumors to their spontaneous mutation rate Cancer Treat Rep 63 11-12 1727 1733 526911 1:STN:280:DyaL3c7htV2ntQ%3D%3D
27. MT Hallissey WH Allum C Roginski JW Fielding 1988 Palliative surgery for gastric cancer Cancer 62 2 440 444 10.1002/1097-0142(19880715)62:2<440::AID- CNCR2820620232>3.0.CO;2-N 2454725 10.1002/1097-0142(19880715)62:2<440:: AID-CNCR2820620232>3.0.CO;2-N 1:STN:280:DyaL1c3ltlWmtw%3D%3D (Pubitemid 18172615)
28. R Martin P Paty Y Fong A Grace A Cohen R DeMatteo W Jarnagin L Blumgart 2003 Simultaneous liver and colorectal resections are safe for synchronous colorectal liver metastasis J Am Coll Surg 197 2 233 241 10.1016/S1072-7515(03) 00390-9 12892803 10.1016/S1072-7515(03)00390-9 (discussion 232-241) (Pubitemid 36927386)
29. SA Rosen JF Buell A Yoshida S Kazsuba R Hurst F Michelassi JM Millis MC Posner 2000 Initial presentation with stage IV colorectal cancer: how aggressive should we be? Arch Surg 135 5 530 534 10.1001/archsurg.135.5.530 10807276 10.1001/archsurg.135.5.530 1:STN:280:DC%2BD3c3msFGmtA%3D%3D (discussion 534-535)
30. K Tanaka H Shimada K Matsuo Y Nagano I Endo H Sekido S Togo 2004 Outcome after simultaneous colorectal and hepatic resection for colorectal cancer with synchronous metastases Surgery 136 3 650 659 10.1016/j.surg.2004.02.012 15349115 10.1016/j.surg.2004.02.012 (Pubitemid 39186580)
31. J Gnerlich DB Jeffe AD Deshpande C Beers C Zander JA Margenthaler 2007 Surgical removal of the primary tumor increases overall survival in patients with metastatic breast cancer: analysis of the 1988-2003 SEER data Ann Surg Oncol 14 8 2187 2194 10.1245/s10434-007-9438-0 17522944 10.1245/s10434-007-9438- 0 (Pubitemid 47174926)
32. SH Giordano GN Hortobagyi 2003 Inflammatory breast cancer: clinical progress and the main problems that must be addressed Breast Cancer Res 5 6 284 288 10.1186/bcr608 14580242 10.1186/bcr608 (Pubitemid 37407148)
33. BTN Lee 1924 Inflammatory carcinoma of the breast: a report of twenty-eight cases from the breast clinic of Memorial Hospital Surg Gynecol Obstet 39 580 595
34. FL Greene 2002 The American Joint Committee on Cancer: updating the strategies in cancer staging Bull Am Coll Surg 87 7 13 15 17387902